CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE: Release of a capital market information
CompuGroup Medical SE
/ Share Buyback
CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 – 7th Interim Announcement, concurrently Completion Announcement CompuGroup Medical SE / Share Buyback
Koblenz, October 31, 2019 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 – 7th Interim Announcement, concurrently Completion Announcement In the period from October 28, 2019, up to and including October 30, 2019, CompuGroup Medical SE has bought back a total of 36,469 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of September 17, 2019, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on September 18, 2019. The share buyback was terminated on October 31, 2019 as per resolution of the Management Board of the same day. The overall volume of the shares bought back daily in the period from October 28, 2019, up to and including October 30, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:
The total number of shares which have been bought back until the termination of the share buyback program by CompuGroup Medical SE since September 18, 2019, up to and including October 30, 2019, within the framework of the share buyback program thus amounts to 415,599 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). The Management Board CompuGroup Medical SE
31.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | CompuGroup Medical SE |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Internet: | www.cgm.com |
End of News | DGAP News Service |